Cite
HARVARD Citation
Gravis, G. et al. (2018). Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen. European journal of cancer. pp. 236-238. [Online].